Stocks Getting Investor’s Attention: BP p.l.c. (NYSE:BP), Yahoo! Inc. (NASDAQ:YHOO), Pall Corporation (NYSE:PLL), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Alliance One International, Inc. (NYSE:AOI)

BP p.l.c. (NYSE:BP) Chief Executive Bob Dudley told staff in a Monday memo that the company would freeze 2015 base pay, part of a larger round of cost savings and cuts the company has undertaken as oil prices remain at less than half the level of mid-2014, a BP spokesman said. BP p.l.c. (NYSE:BP) belongs to Basic Materials sector. Its net profit margin is 2.50% and weekly performance is 5.44%. On last trading day company shares ended up $39.92. BP p.l.c. (NYSE:BP) distance from 50-day simple moving average (SMA50) is 2.86%.

Yahoo Inc’s (NASDAQ:YHOO) shares are expected to move nearly twice as much as they have following other recent earnings reports when the company announces fourth-quarter results on Tuesday, options data showed. Yahoo! Inc. (NASDAQ:YHOO) shares moved up 1.00% in last trading session and ended the day at $49.44. YHOO Gross Margin is 71.90% and its return on assets is 28.80%. Yahoo! Inc. (NASDAQ:YHOO) quarterly performance is 16.06%.

Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc. (OTCQB: ORGS), announced that Orgenesis and Pall Corporation (NYSE:PLL) have received an $800,000 grant from the Israel-U.S. Binational Industrial Research and Development (“BIRD”) Foundation to finance their current $1,600,000 co-development program. On 26 January, Pall Corporation (NYSE:PLL) shares moved up 0.67% and was closed at $101.39. PLL EPS growth in last 5 year was 14.70%. Pall Corporation (NYSE:PLL) year to date (YTD) performance is 0.18%.

On Jan. 12, Halozyme Therapeutics, Inc. (NASDAQ: HALO) provided an update on anticipated 2015 corporate milestones. Present Phase 1b (Study 201) results at ASCO-GI (poster scheduled for January 16, 2015). Complete patient enrollment in the on-going Phase 2 multi-center, randomized clinical trial (Study 202) evaluating PEGPH20 as a first-line therapy for patients with stage IV metastatic pancreatic cancer, in the second half of 2015. Halozyme Therapeutics, Inc. (NASDAQ:HALO) ended the last trading day at $14.44. Company weekly volatility is calculated as 6.24% and price to cash ratio as 13.46. Halozyme Therapeutics, Inc. (NASDAQ:HALO) showed a weekly performance of -2.56%.

Alliance One International, Inc. (NYSE:AOI) shares remains unchanged in last trading session and ended the day at $1.29. AOI Gross Margin is 11.10% and its return on assets is -1.30%. Alliance One International, Inc. (NYSE:AOI) quarterly performance is -35.18%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone